• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Claritev and Burjeel Holdings Partner to Advance Revenue Integrity Solutions in the MENA Region

    4/25/25 8:00:00 AM ET
    $CTEV
    Real Estate
    Real Estate
    Get the next $CTEV alert in real time by email

    Claritev and Claims Care Revenue Cycle Management, a Burjeel Holdings Company, sign an MoU to bring the US-based Claritev's solutions to the MENA region and collaborate on revenue cycle management capabilities

    Claritev Corporation ("Claritev") (NYSE:CTEV) and Claims Care Revenue Cycle Management LLC ("Claims Care" or "CCRCM"), a division of Burjeel Holdings (ADX: BURJEEL), have signed a memorandum of understanding (MOU) to leverage Claritev's Payment and Revenue Integrity solutions for the Middle East and North Africa regional payer market and create a joint product roadmap to offer advanced revenue cycle management (RCM) capabilities in the region.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250424067343/en/

    This collaboration brings two industry leaders from the U.S. and MENA markets together, with an aim to offer innovation and technology that promotes affordable, transparent and higher quality healthcare services. The partnership also marks a significant milestone in Claritev's mission to expand its footprint globally and offer its highly scalable products to new markets.

    Under the terms of the MOU, Claritev and Claims Care will combine their resources, domain expertise and regional networks to co-create transformative RCM offerings. These solutions will incorporate Claritev's capabilities in Advanced Code Editing and Decision Science with Claims Care's deep expertise and regional leadership in revenue cycle management to streamline the reimbursement process. The alliance also involves the transition of certain offshore business processes to Claims Care, further deepening operational synergies and market alignment.

    "At Burjeel Holdings, we are constantly exploring ways to elevate healthcare delivery through innovation and strategic collaboration. Our partnership with Claritev marks a major step toward transforming revenue cycle management in MENA. By integrating Claritev's world-class technology with Claims Care's deep market expertise, we aim to drive greater efficiency, transparency and value across the healthcare ecosystem," said John Sunil, Group CEO, Burjeel Holdings.

    "Global healthcare is at an inflection point and we are uniquely positioned to transform it with technology and data," said Travis Dalton, Chairman, CEO and President of Claritev. He continued, "Claims Care is one of the largest RCM providers in the Middle East, a key component of Burjeel Holding's integrated healthcare network, and most importantly, is aligned with our vision of providing innovative solutions across the healthcare ecosystem."

    About Claritev

    Claritev, formerly known as MultiPlan, is a healthcare technology, data and insights company focused on delivering affordability, transparency and quality to the U.S. healthcare system. Led by a team of deeply experienced associates, data scientists, and innovators, Claritev provides cutting-edge solutions and services fueled by over 40 years of claims processing data. Claritev leverages world-class technology and AI to power a robust enterprise platform that delivers meaningful insights to drive affordability and price transparency, and optimizes networks and benefits design in healthcare. By developing purpose-build solutions that support all key stakeholders – including payors, employers, patients, providers and third parties – Claritev is dedicated to making healthcare more accessible and affordable for all.

    Claritev serves more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit claritev.com.

    About Claims Care Revenue Cycle Management LLC

    Established in 2016, Claims Care Revenue Cycle Management (Claims Care) is one of the largest independent revenue cycle management providers in the MENA region. Operating under Burjeel Holdings—a leading superspecialty healthcare services provider in the MENA region and listed on the Abu Dhabi Securities Exchange (ADX)—Claims Care has 1,000 employees across four international locations and operates highly automated, complex billing and claims management systems. Leveraging AI-based coding, resubmission, paperless authorization, analytical dashboards, and RPA-assisted eligibility verification, Claims Care manages over 3.5 million records, 5.4 million claims, and 1500+ key contracts. Comprehensive solutions span from patient registration to reimbursement. Additional offerings include medical transcription, business and revenue intelligence analytics, and quality assurance audits. Through partnerships with leading insurers, Claims Care is committed to streamlining administrative workflows and strengthening the delivery of patient-centered care across the region.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250424067343/en/

    Media Relations

    Pamela Walker

    VP, Corporate Marketing

    Claritev

    781-895-3118

    [email protected]

    Investor Relations

    Jason Wong

    SVP, Treasury & Investor Relations

    Claritev

    866-909-7427

    [email protected]

    Shawna Gasik

    AVP, Investor Relations

    Claritev

    866-909-7427

    [email protected]

    Get the next $CTEV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CTEV

    DatePrice TargetRatingAnalyst
    1/12/2026$43.00Buy
    Guggenheim
    1/9/2026$33.00Equal Weight
    Wells Fargo
    10/21/2025$74.00Neutral → Buy
    Citigroup
    5/29/2025$44.00Neutral → Overweight
    Piper Sandler
    More analyst ratings

    $CTEV
    SEC Filings

    View All

    SEC Form DEFA14A filed by Claritev Corporation

    DEFA14A - Claritev Corp (0001793229) (Filer)

    3/20/26 6:45:55 AM ET
    $CTEV
    Real Estate

    SEC Form DEF 14A filed by Claritev Corporation

    DEF 14A - Claritev Corp (0001793229) (Filer)

    3/20/26 6:43:45 AM ET
    $CTEV
    Real Estate

    Claritev Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Claritev Corp (0001793229) (Filer)

    3/16/26 5:05:40 PM ET
    $CTEV
    Real Estate

    $CTEV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Albinson Brock

    4 - Claritev Corp (0001793229) (Issuer)

    4/2/26 5:06:44 PM ET
    $CTEV
    Real Estate

    EVP&CFO Garis Douglas Michael bought $22,997 worth of shares (1,300 units at $17.69), increasing direct ownership by 0.63% to 206,152 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    3/16/26 12:31:02 PM ET
    $CTEV
    Real Estate

    EVP, Chief Digital Officer Kim Michael bought $247,500 worth of shares (15,000 units at $16.50), increasing direct ownership by 9% to 182,878 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    3/16/26 8:42:00 AM ET
    $CTEV
    Real Estate

    $CTEV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Claritev Corporation Announces Participation in Upcoming Events

    Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that members of its management team will meet with investors at the following investor events in March 2026: Mizuho Virtual Healthcare Technology Conference 2026 – Thursday, March 5, 2026 - 1x1 meetings hosted virtually Q&A Webcast Hosted by Nephron Research – Friday, March 6, 2026 at 11 a.m. ET. (Webcast details below) Barclays 28th Annual Global Healthcare Conference – Wednesday, March 11, 2025, at the Loews Miami Beach Hotel, Miami Beach, FL - 1x1 meetings To listen to the Q&A we

    3/4/26 8:00:00 AM ET
    $CTEV
    Real Estate

    Claritev Corporation To Host 2026 Investor Day

    Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, will host its 2026 Investor Day on Monday, March 16, 2026 at the New York Stock Exchange. The event will feature presentations by members of Claritev's management team discussing the company's long term growth strategy, vertical markets, product roadmap, and financial outlook, along with conversations with a number of clients and partners. The event and a live webcast will begin at 1:00 p.m. ET. Registration for the webcast can be found at https://www.claritev.com/investor-day-2026/. An archive of the webcast wi

    3/3/26 1:58:00 PM ET
    $CTEV
    Real Estate

    Claritev Corporation Reports Fourth Quarter and Full Year 2025 Results

    Q4 2025 Revenues of $246.6 million, Net loss of $80.6 million, and Adjusted EBITDA of $151.3 million (Adjusted EBITDA Margin of 61.4%) Full-year 2025 Revenues of $965.4 million (increase of 3.7% compared to FY 2024), Net loss of $284.3 million, and Adjusted EBITDA of $602.6 million (increase of 4.5% compared to FY 2024) Full-year 2026 Guidance initiated: Revenue range of $980 million to $1 billion Free cash flow of $0 million to $10 million Capital expenditures of $160 million to $170 million Company Board of Directors approves $75 million, five-year share repurchase program Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insigh

    2/23/26 4:05:00 PM ET
    $CTEV
    Real Estate

    $CTEV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Guggenheim initiated coverage on Claritev with a new price target

    Guggenheim initiated coverage of Claritev with a rating of Buy and set a new price target of $43.00

    1/12/26 8:12:35 AM ET
    $CTEV
    Real Estate

    Wells Fargo initiated coverage on Claritev with a new price target

    Wells Fargo initiated coverage of Claritev with a rating of Equal Weight and set a new price target of $33.00

    1/9/26 9:03:34 AM ET
    $CTEV
    Real Estate

    Claritev upgraded by Citigroup with a new price target

    Citigroup upgraded Claritev from Neutral to Buy and set a new price target of $74.00

    10/21/25 7:13:03 AM ET
    $CTEV
    Real Estate

    $CTEV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP&CFO Garis Douglas Michael bought $22,997 worth of shares (1,300 units at $17.69), increasing direct ownership by 0.63% to 206,152 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    3/16/26 12:31:02 PM ET
    $CTEV
    Real Estate

    EVP, Chief Digital Officer Kim Michael bought $247,500 worth of shares (15,000 units at $16.50), increasing direct ownership by 9% to 182,878 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    3/16/26 8:42:00 AM ET
    $CTEV
    Real Estate

    EVP, Chief Digital Officer Kim Michael bought $428,955 worth of shares (30,000 units at $14.30), increasing direct ownership by 28% to 137,973 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    3/2/26 5:01:41 PM ET
    $CTEV
    Real Estate

    $CTEV
    Financials

    Live finance-specific insights

    View All

    Claritev Corporation Reports Fourth Quarter and Full Year 2025 Results

    Q4 2025 Revenues of $246.6 million, Net loss of $80.6 million, and Adjusted EBITDA of $151.3 million (Adjusted EBITDA Margin of 61.4%) Full-year 2025 Revenues of $965.4 million (increase of 3.7% compared to FY 2024), Net loss of $284.3 million, and Adjusted EBITDA of $602.6 million (increase of 4.5% compared to FY 2024) Full-year 2026 Guidance initiated: Revenue range of $980 million to $1 billion Free cash flow of $0 million to $10 million Capital expenditures of $160 million to $170 million Company Board of Directors approves $75 million, five-year share repurchase program Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insigh

    2/23/26 4:05:00 PM ET
    $CTEV
    Real Estate

    Claritev Corporation Announces Fourth Quarter 2025 Earnings Conference Call

    Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its fourth quarter and fiscal year 2025 financial results after market close on Monday, February 23, 2026, and hold a conference call at 4:30 pm Eastern Time. To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique PIN. Pre-registration may be completed at any time up to and following the call start time. To pre-register, go to the following

    1/29/26 8:00:00 AM ET
    $CTEV
    Real Estate

    Claritev Corporation Reports Third Quarter 2025 Results

    – Q3 2025 Revenues of $246.0 million grew 6.7% compared to Q3 2024 – Net Loss of $69.8 million – Adjusted EBITDA of $155.1 million increased 9.5% compared to Q3 2024 (Adjusted EBITDA Margin of 63.1% versus 61.5% in Q3 2024) – Claritev raises full-year 2025 revenue and Adjusted EBITDA guidance Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the third quarter ended September 30, 2025. "We declared 2025 would be the Year of the Turn at Claritev. Our third quarter results and increased full year guidance demonstrate that w

    11/7/25 6:00:00 AM ET
    $CTEV
    Real Estate

    $CTEV
    Leadership Updates

    Live Leadership Updates

    View All

    Claritev Releases 2024 Corporate Responsibility Report

    Third annual report highlights the company's commitment to social and environmental stewardship Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the publication of its 2024 Corporate Responsibility Report. The 2024 report showcases the Company's strategic momentum in advancing its sustainability priorities during a pivotal year of transformation. The report emphasizes Claritev's continued focus on managing, tracking and disclosing its social and environmental performance, reinforcing its commitment to accountability and responsible

    7/16/25 9:00:00 AM ET
    $CTEV
    Real Estate

    Claritev Appoints Mohamed Ramzy as SVP and General Manager, International to Lead Geographic Expansion; Signs with Halian to Support Regional Operations

    Strategic leadership and operational collaboration underscore Claritev's commitment to growth in the Middle East and international business development outside the US Claritev Corporation ("Claritev") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced it is deepening its investment in the Middle East North Africa ("MENA") region and the market outside the United States with the appointment of new regional leadership and a strategic operational collaboration. These moves reflect Claritev's continued focus on expanding its footprint and delivering localized, high-impact healthcare technology soluti

    5/28/25 8:00:00 AM ET
    $CTEV
    Real Estate

    Great Speech's Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev's National PPO Networks

    HOLLYWOOD, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Great Speech, a national leader in virtual speech therapy, is proud to announce a new agreement with Claritev, formerly known as MultiPlan (NYSE:CTEV), a technology and data insights company focused on making healthcare more affordable, transparent and fair for all. This network participation agreement marks a major step forward in expanding access to high-quality, convenient, and personalized speech therapy services for individuals and families nationwide. Great Speech's innovative teletherapy services will now be available to health plan members accessing Claritev's MultiPlan and PHCS Networks. The initiative aims to eliminate traditio

    5/6/25 10:02:00 AM ET
    $CTEV
    Real Estate